NCT03413579 2021-08-25CIMAHOPEEl Kendi Pharmaceuticals Manufacturing CompanyPhase 3 Completed37 enrolled
NCT02095119 2015-04-14A Monoclonal Antibody, Nimotuzumab, as Treatment for Recurrent or Metastatic Cervical CancerNational Institute of CancerologíaPhase 1/2 Completed15 enrolled